Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 124

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

KIM-1 and NGAL: new markers of obstructive nephropathy

Wasilewska, Anna, Taranta-Janusz, Katarzyna, Dębek, Wojciech, Zoch-Zwierz, Walentyna, Kuroczycka-Saniutycz, Elżbieta · 2011 · Pediatric Nephrology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00467-011-1773-5

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 27

  1. Smith JM, Stablein DM, Munoz R, Hebert D, McDonald RA (2007) Contributions of the transplant registry: The 2006 Annual Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS). Pediatr Transplant 11:366–373 · DOI · Paper page
  2. Chevalier RL, Thornhill BA, Forbes MS, Kiley SC (2010) Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy. Pediatr Nephrol 25:687–697 · DOI · Paper page
  3. Nickolas TL, Barasch J, Devarajan P (2008) Biomarkers in acute and chronic kidney disease. Curr Opin Nephrol Hypertens 17:127–132 · DOI · Paper page
  4. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch J (2008) Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148:810–819 · DOI · Paper page
  5. Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Yoshioka T, Ogawa Y, Imamaki H, Kusakabe T, Ebihara K, Omata M, Satoh N, Sugawara A, Barasch J, Nakao K (2009) Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli, proximal tubules, and distal nephrons. Kidney Int 75:285–294 · DOI · Paper page
  6. Ding H, He Y, Li K, Yang J, Li X, Lu R, Gao W (2007) Urinary neutrophil gelatinase-associated lipocalin (NGAL) is an early biomarker for renal tubulointerstitial injury in IgA nephropathy. Clin Immunol 123:227–234 · DOI · Paper page
  7. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J Biol Chem 273:4135–4142 · DOI · Paper page
  8. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV (2004) Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am J Physiol Renal Physiol 286:F552–F563 · DOI · Paper page
  9. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV (2006) Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am J Physiol Renal Physiol 290:F517–F529 · DOI · Paper page
  10. Chaturvedi S, Farmer T, Kapke GF (2009) Assay validation for KIM-1: human urinary renal dysfunction biomarker. Int J Biol Sci 5:128–134 · DOI
  11. Bonventre JV (2009) Kidney injury molecule-1 (KIM-1): a urinary biomarker and much more. Nephrol Dial Transplant 24:3265–3268 · DOI · Paper page
  12. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA (2007) Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol 212:209–217 · DOI · Paper page
  13. Fernbach SK, Maizels M, Conway JJ (1993) Ultrasound grading of hydronephrosis: introduction to the system used by the Society for Fetal Urology. Pediatr Radiol 23(6):478–480 · DOI · Paper page
  14. Kajbafzadeh AM, Elmi A, Talab SS, Emami H, Esfahani SA, Saeedi P (2010) Urinary and serum carbohydrate antigen 19-9 as a biomarker in ureteropelvic junction obstruction in children. J Urol 183:2353–2360 · doi:10.1016/j.juro.2010.02.031
  15. Chertin B, Pollack A, Koulikov D, Rabinowitz R, Hain D, Hadas-Halpren I, Farkas A (2006) Conservative treatment of ureteropelvic junction obstruction in children with antenatal diagnosis of hydronephrosis: lessons learned after 16 years of follow-up. Eur Urol 49:734–738 · doi:10.1016/j.eururo.2006.01.046
  16. Madden NP, Thomas DF, Gordon AC, Arthur RJ, Irving HC, Smith SE (1991) Antenatally detected pelviureteric junction obstruction. Is non-operation safe? Br J Urol 68:305–310 · doi:10.1111/j.1464-410x.1991.tb15329.x
  17. Chevalier RL (2006) Obstructive nephropathy: towards biomarker discovery and gene therapy. Nat Clin Pract Nephrol 2:157–168 · DOI · Paper page
  18. Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, Miller TJ, Bonventre JV, Goering PL (2008) Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci 101:159–170 · DOI · Paper page
  19. Huo W, Liu R, Zhang K, Nie J, Li Q, Jin F (2010) Kidney injury molecule-1: a novel kidney-specific injury molecule playing potential double-edged functions in kidney injury. J Nephrol. doi: 10.5301/JN.2010.5800 · doi:10.5301/jn.2010.5800
  20. Chevalier RL, Thornhill BA, Wolstenholme JT, Kim A (1999) Unilateral ureteral obstruction in early development alters renal growth: dependence on the duration of obstruction. J Urol 161:309–313 · doi:10.1016/s0022-5347(01)62137-2
  21. Brunner HI, Mueller M, Rutherford C, Passo MH, Witte D, Grom A, Mishra J, Devarajan P (2006) Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum 54:2577–2584 · DOI · Paper page
  22. Bolignano D, Coppolino G, Campo S, Aloisi C, Nicocia G, Frisina N, Buemi M (2007) Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease. Am J Nephrol 27:373–378 · DOI
  23. Bolignano D, Lacquaniti A, Coppolino G, Campo S, Arena A, Buemi M (2008) Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease. Kidney Blood Press Res 31(4):255–258 · DOI
  24. Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG (2005) Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280:7875–7882 · DOI · Paper page
  25. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15:3073–3082 · DOI · Paper page
  26. Devarajan P (2008) Emerging urinary biomarkers in the diagnosis of acute kidney injury. Expert Opin Med Diagn 2:387–398 · DOI
  27. Wasilewska A, Zoch-Zwierz W, Taranta-Janusz K, Michaluk-Skutnik J (2010) Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of cyclosporine nephrotoxicity? Pediatr Nephrol 25:889–897 · DOI

Cited by

See all 124

Metadata

Authors
Wasilewska, A., Taranta-Janusz, K., Dębek, W., Zoch-Zwierz, W., & Kuroczycka-Saniutycz, E.
Venue
Pediatric Nephrology
Published
2011-01-31
Volume
26
Issue
4
Pages
579-586
ISSN
  • 0931-041X
  • 1432-198X
Cited by
124
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: KIM-1 and NGAL: new markers of obstructive nephropathy. https://app.cochat.ai/papers/10.1007/s00467-011-1773-5
The paper
Wasilewska, A., Taranta-Janusz, K., Dębek, W., Zoch-Zwierz, W., & Kuroczycka-Saniutycz, E. (2011). KIM-1 and NGAL: new markers of obstructive nephropathy. Pediatric Nephrology. https://doi.org/10.1007/s00467-011-1773-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.